(Q29617267)

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=18468541

30 April 2017

main subject

mesenchymal stem cell

1 reference

Le Blanc K

1

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=18468541

30 April 2017

Frassoni F

2

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=18468541

30 April 2017

Ball L

3

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=18468541

30 April 2017

Locatelli F

4

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=18468541

30 April 2017

Roelofs H

5

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=18468541

30 April 2017

Lewis I

6

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=18468541

30 April 2017

Lanino E

7

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=18468541

30 April 2017

Sundberg B

8

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=18468541

30 April 2017

Bernardo ME

9

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=18468541

30 April 2017

Remberger M

10

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=18468541

30 April 2017

Dini G

11

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=18468541

30 April 2017

Egeler RM

12

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=18468541

30 April 2017

Bacigalupo A

13

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=18468541

30 April 2017

Fibbe W

14

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=18468541

30 April 2017

Ringdén O

15

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=18468541

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=18468541

30 April 2017

language of work or name

1 reference

30 April 2017

publication date

10 May 2008

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=18468541

30 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=18468541

30 April 2017

volume

371

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=18468541

30 April 2017

issue

9624

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=18468541

30 April 2017

page(s)

1579-86

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=18468541

Marrow transplantation for patients in the chronic phase of chronic granulocytic leukaemia

30 April 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960690-X

7 January 2021

Graft-versus-host disease in dog and man: the Seattle experience

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960690-X

7 January 2021

Death by graft-versus-host disease associated with HLA mismatch, high recipient age, low marrow cell dose, and splenectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960690-X

7 January 2021

How I treat refractory acute GVHD.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960690-X

7 January 2021

Characterization of cells with osteogenic potential from human marrow

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960690-X

7 January 2021

Mesenchymal stem cells promote engraftment of human umbilical cord blood-derived CD34(+) cells in NOD/SCID mice

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960690-X

7 January 2021

T cell responses to allogeneic human mesenchymal stem cells: immunogenicity, tolerance, and suppression

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960690-X

7 January 2021

Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960690-X

7 January 2021

Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960690-X

7 January 2021

Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fibrotic effects

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960690-X

7 January 2021

Administered mesenchymal stem cells protect against ischemic acute renal failure through differentiation-independent mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960690-X

7 January 2021

Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960690-X

7 January 2021

Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: Implications for cell therapy of bone

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960690-X

7 January 2021

Cotransplantation of HLA-identical sibling culture-expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960690-X

7 January 2021

Rapid hematopoietic recovery after coinfusion of autologous-blood stem cells and culture-expanded marrow mesenchymal stem cells in advanced breast cancer patients receiving high-dose chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960690-X

7 January 2021

Cotransplantation of ex vivo expanded mesenchymal stem cells accelerates lymphocyte recovery and may reduce the risk of graft failure in haploidentical hematopoietic stem-cell transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960690-X

7 January 2021

Transplantation of mesenchymal stem cells to enhance engraftment of hematopoietic stem cells

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960690-X

7 January 2021

Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960690-X

7 January 2021

Mesenchymal Stem Cells for Treatment of Therapy-Resistant Graft-versus-Host Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960690-X

7 January 2021

Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960690-X

7 January 2021

Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statement.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960690-X

7 January 2021

Estimation of failure probabilities in the presence of competing risks: new representations of old estimators

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960690-X

7 January 2021

Treatment of severe acute graft-versus-host disease with anti-thymocyte globulin

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960690-X

7 January 2021

Human mesenchymal stem cells modulate allogeneic immune cell responses

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960690-X

7 January 2021

Immunobiology of human mesenchymal stem cells and future use in hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960690-X

7 January 2021

Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960690-X

7 January 2021

10.1016/S0140-6736(08)60690-X

Identifiers

DOI

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=18468541

30 April 2017

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

297024

OpenCitations bibliographic resource ID

297024

1 reference